Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

TM-β-CD improves finasteride's solubility and delivery, while β-CD offers better long-term release.

Cedrol promotes hair growth better than baricitinib by regulating immune cells.

Scientists identified three genes important for processing certain brain chemicals, thyroid hormones, and medications.

5α-Reductase helps regulate hormone action in toad testes, especially during breeding season.

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

PROTACs show promise for cancer treatment, but designing them effectively is challenging.

Clascoterone cream could be used for other skin conditions affected by hormones.

CLE40 and CRN/CLV2 pathways have opposite effects on root growth in Arabidopsis.

CXXC5 is a protein that prevents hair growth and could be a target for hair loss treatment.

LGD1069 effectively prevents breast tumors in mice without toxicity.

Tirzepatide improved symptoms and hair regrowth in a man with folliculitis decalvans.

CRET therapy affects inflammation in skin cells by changing cytokine levels and activating certain proteins.

Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.

Taking oral isotretinoin with creams worked better for treating a type of hair loss than creams alone.

CAP1/Prss8 does not activate PAR2 or inhibit PN-1.

Finasteride may affect brain chemistry and behavior, offering potential for treating certain mental health conditions.

Topical tacalcitol ointment can help improve symptoms of EFFC.

The PCL/PHB blend allows for slower, more controlled curcumin release than individual polymers.

Coinheritance of BRCA2 and CYLD genes may lead to new treatment options for certain cancers.

A specific mutation in the TRPV3 gene causes hair follicle cells to develop improperly, leading to hair loss.

Certain genetic variations are linked to higher liver enzyme levels in patients treated for chronic hepatitis C with specific drugs.

MC-DNA vector-based gene therapy can temporarily treat CBS deficiency in mice.

Certain peptides can prevent hair loss in young rats caused by a cancer drug.

Intralesional cidofovir may be a viable alternative treatment for SCC.

Tamsulosin's sulfonamide group may contribute to floppy iris syndrome.

Overexpression of hurpin in mice leads to abnormal skin and higher skin cancer risk.